Skip to main content
. 2017 Jul-Aug;32(4):276–282. doi: 10.21470/1678-9741-2017-0031

Table 1.

Demographic details.

  Group 1 ≤ 6 hrs (n=99) Group 2 > 6 hrs (n=36) Pvalue
Age (months) 26.37 ± 30.89 18.5 ± 26.2 0.019
Sex (male) (56.56%) (50%) 0.7869
Weight (kg) 7.85 ± 4.14 6.38 ± 3.68 0.005
Malnutrition 88 (87.8%) 32 (91.6%) 0.808
Trisomy 21 (n, %) 2 (3%) 7 (16.6%) 0.015
Type of VSD      
    Perimembranous (n, %) 68 (68.6%) 20 (55.5%) 0.225
    Subaortic (n, %) 19 (19.1%) 10 (27.7%) 0.402
    Muscular (n, %) 12 (12.1%) 6 (16.6%) 0.688
Size of VSD      
    Small VSD (n, %) 24 (25.2%) 7 (16.6%) 0.802
    Moderate VSD (n, %) 4 (4.04%) __ 0.533
    Large VSD (n, %) 72 (70.7%) 28 (83.3%) 0.480
PAH      
    Mild PAH (n, %) 20 (21.21%) 3 (5.5%) 0.198
    Moderate PAH (n, %) 10 (10.10%) 3 (8.3%) 0.931
    Severe PAH (n, %) 70 (68.68%) 29 (86.1%) 0.208
Lesions      
    Single VSD (n, %) 80 (79.79%) 23 (66.6%) 0.139
    Multiple VSD (n, %) 5 (5.05%) 7 (19.4%) 0.019
    VSD+PDA (n, %) 3 (3.03%) 1 (2.7%) 0.618
    VSD+ASD (n, %) 12 (12.12%) 4 (11.1%) 0.888

VSD=ventricular septal defect; ASD=atrial septal defect; PAH=pulmonary arterial hypertension; PDA=patent ductus arteriosus